DDBC3D1 Evera S
Implantable Cardioverter Defibrillator (ICD)
DDBC3D1 Evera S
Information

Device Survival Probability

EVERA_DR_SURV
Loading...










    1 yr 2 yr 3 yr 4 yr 5 yr 6 yr 7 yr 8 yr 9 yr 10 yr at 127.0 mo                    
% Excluding Normal Battery Depletion 100.0 100.0 100.0 99.9 99.9 99.8 99.8 99.7 99.7 99.7 99.7                    
% Including Normal Battery Depletion 99.9 99.9 99.8 99.7 99.5 99.1 97.8 94.8 89.5 76.7 52.0                    
#   218225 198372 176480 156414 129273 100416 72513 46264 24723 8359 916                    
  • Including Normal Battery Depletion – This curve includes devices that have reached at least 80% of expected longevity. This curve is most representative of clinical performance and how long the device will last.
  • Excluding Normal Battery Depletion – This is the malfunction free survival curve.
Information

Product Characteristics

Generator Type ICD
NBD Code DDE-DDDR
Max. Delivered Energy 36 J
More
Connector Style DR Style
Serial Number Prefix BWG
Mass 77 g
Volume 33 cc
Waveform Biphasic
X-Ray ID PXT
Hide this content
DR Style
Information

Estimated Longevity

Charging Frequency 100% Pacing 50% Pacing 15% Pacing 100% Sensing
Monthly 4.1 4.6 5.1 5.4
Quarterly 5.9 7.0 8.3 9.0
Semi-annual 6.2 7.6 9.0 9.8
Footnote

Longevity estimates based on the following device usage. Pacing Mode DDD; Atrial Lower Pacing Rate 60ppm; Ventricular Lower Pacing Rate 60ppm; Atrial Pulse Width 0.4ms; Ventricular Pulse Width 0.4ms; Atrial Pulse Amplitude 3V; Ventricular Pulse Amplitude 3V; Atrial Impedance 510ohms; Ventricle Impedance 510ohms; Atrial Sensing Rate 70bpm; Ventricle Sensing Rate 70bpm; EGM prestorage OFF; Optivol ON; Atrial Fib percentage of time 0%; Charging frequency assumes maximum energy charge and includes therapy shocks and capacitor formation. Hide this content

Information

Distribution Data

US Market Release2013-04-03
CE Approval Date2012-12-17
Registered USA Implants8434
Estimated Active USA Implants3729
Normal Battery Depletions864
US Market Release2013-04-03
CE Approval Date2012-12-17
Estimated WW Distribution23620
Normal Battery Depletions871
Information

Malfunctions (USA)

Therapy Function Not Compromised 9
Battery 7
Electrical Component 2
Therapy Function Compromised 9
Battery 6
Device-Related Current Pathway 1
Electrical Component 2
Information

Malfunctions (WW)

Therapy Function Not Compromised 25
Battery 20
Electrical Component 5
Therapy Function Compromised 14
Battery 10
Device-Related Current Pathway 2
Electrical Component 2
Information

EOS Indication

From the point that the RRT is set, the pacemaker will operate for approximately three months for typical pacemaker configurations during the normal operating life.

Information

Recommended Replacement (RRT)

Battery voltage less than or equal to 2.73V on 3 consecutive daily automatic measurments.

Information

Charge Time

BLACKWELL_DR_CHRG
Loading...

Data as of November 20, 2024

www.medtronic.com/productperformance 1026050